关键词:
pulse oximetry
plethysmography
cardiac output
stroke volume
waveform analysis
摘要:
Objective: To assess the relation between photoplethysmographically-derived parameters and invasively-determined hemodynamic variables. Design: After induction of anesthesia and placement of a Swan-Ganz CCOmbo catheter, a Nonin OEM III probe was placed on each patient's earlobe. Photoplethysmographic signals were recorded in conjunction with cardiac output. Photoplethysmographic metrics (amplitude of absorbance waveform, maximal slope of absorbance waveform, area under the curve, and width) were calculated offline and compared with invasively determined hemodynamic variables. Subject-specific associations between each dependent and independent variable pair were summarized on a per-subject basis by the nonparametric Spearman rank correlation coefficient. The bias-corrected accelerated bootstrap resampling procedure of Efron and Tibshirani was used to obtain a 95% confidence interval for the median subject-specific correlation coefficient, and Wilcoxon sign-rank tests were conducted to test the null hypothesis that the median of the subject-specific correlation coefficients were equal to 0. Setting: University hospital. Participants: Eighteen patients undergoing coronary artery bypass graft surgery. Interventions: Placement of a Swan-Ganz CCOmbo catheter and a Nonin OEM III pulse oximetry probe. Measurements and main results: There was a positive, statistically significant correlation between stroke volume and width (median correlation coefficient, 0.29;confidence interval, 0.01-0.46;p = 0.034). The concordance between changes in stroke volume and changes in width was 53%. No other correlations achieved statistical significance. Conclusions: This study was unable to reproduce the results of prior studies. Only stroke volume and photoplethysmographic width were correlated in this study;however, the correlation and concordance (based on analysis of a 4-quadrant plot) were too weak to be clinically useful. Future studies in patients undergoing low-to-moderate risk surge